Beijing Diwei Huayu Biotechnology Co., Ltd., established on 2001-03-28, Business scope includes technical development of biological products,Serve,transfer,consult,training;Sales of developed products;Investment Advisory;law,Administrative regulations,banned by the State Council,Not allowed to operate;law,Administrative regulations,Decisions of the State Council require permission,It can only be operated after being approved by the examination and approval authority and registered by the industrial and commercial administrative authority;law,Administrative regulations,The decision of the State Council does not provide for permission,Independently choose business projects to carry out business activities.(Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments.)

Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Amedeo Nappi SpA operates as a chemical company. It specializes in production of waxes, paraffins, microcristalline, emulsions, and special blends. The company was founded in 1967 and is headquartered in Liveri, Italy.

Hayashibara Biochemical Laboratories, Inc. manufactures food and cosmetic products. It also makes health food ingredients, functional dyes, and reagents. The company was founded in 1970 and is headquartered in Okayamashi, Japan.

Ciba-Corporate Insurance Brokers Association A/S operates as specialized insurance brokers. It offers insurance solutions and daily administration for companies both nationally and internationally. The firm provides analysis of risks, including adaptation; solution proposals and market research; online access to policies and meetings; risk report; and treatment of injuries. The company was founded on June 19, 2014 and is headquartered in Ballerup, Denmark.

CanSino Biologics, Inc. engages in the research and development, manufacturing, and sale of vaccines. It offers shingles, meningitis, polio, adenovirus, and tuberculosis vaccines. The company was founded by Xuan Liu, Xue Feng Yu, Tao Zhu, Dong Xu Qiu and Hui Hua Mao on January 13, 2009 and is headquartered in Tianjin, China.

Xuzhou Hairun Biotechnology Co., Ltd., established on 2015-04-01, Business scope includes biotechnology research and development,Transfer and technical consulting services;I,II,IIIClass medical device sales,lease;Daily necessities,Office Supplies,electronic product,cosmetic,Health product sales;instrument,Instrument sales,repair;Refrigeration equipment sales and installation services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Gu��rin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder�� Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan.

Northwest Biotherapeutics is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States and is incorporated in Delaware, USA. Currently approved cancer treatments are frequently ineffective, can cause undesirable side effects and provide marginal clinical benefits. The Company’s approach in developing cancer therapies utilizes its expertise in the biology of dendritic cells, which are a type of white blood cell that activate the immune system. The Company’s cancer therapies have been demonstrated in clinical trials to significantly extend both time to recurrence and survival, whilst providing a superior quality of life with no debilitating side effects when compared with current therapies.

Aeras is a global nonprofit biotech with a mission to develop new tuberculosis vaccines that are affordable and accessible to all who need them. Aeras has capabilities in finance, portfolio management, immunology, assay development, clinical trials, regulatory affairs and policy, advocacy and resource mobilization, as well as in-house capacity to conduct pilot manufacturing. Serving as a critical translational bridge from the bench to the field, Aeras has sponsored and conducted over 25 clinical vaccine trials enrolling thousands of subjects, and is a key partner in six active clinical development programs. Aeras has approximately 160 employees, with offices in Rockville, Maryland; Cape Town, South Africa; and Beijing, China.

Panru Biotechnology (Tianjin) Co., Ltd., established on 2022-03-08, Business scope includes general items:Medical Research and Experimental Development;Development of Human Gene Diagnosis and Therapy Technology;Biochemical product technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products);Specialty Chemicals Sales(Free of Hazardous Chemicals).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shanghai Public Health Clinical Center is a Chinese company located in Shanghai and ultimately controlled by the Government of China that operates hospital and provides education and training for disease control and prevention.

International Centre For Genetic Engineering & Biotechnology is an Italian private company. The firm operates as a center for genetic engineering and biotechnology.

Seegene, Inc. engages in the manufacturing and distributing of molecular diagnostics and reagents. Its diagnostic services include respiratory pathogen, gastrointestinal pathogen, sexually transmitted infections, human papillomavirus, tuberculosis, sepsis, meningitis, and pathogen. The company was founded by Jong-Yoon Chun on September 16, 2000 and is headquartered in Seoul, South Korea.

Changchun Biological Products Research Institute Co., Ltd., established on 1985-12-05, Business scope includes manufacturing of biological products,distribution;Operate the research and development and production export business of the Institute and its directly affiliated enterprises, as well as the import business of raw and auxiliary materials, machinery, equipment, instruments, instruments and spare parts required for production and scientific research.;road general cargo transportation;Dedicated transport of goods;Cold chain transportation(Refrigeration and preservation equipment);Biotechnology Consulting,Technical Services;pharmaceutical equipment,Cold storage and workshop leasing services;Warehousing Services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)*

Chengdu Keen Biological Technology Co., Ltd. is a company headquartered in Chengdu, China, that engages in research and development of tuberculosis diagnostic biological products and therapeutic vaccines. It was founded in 2018.